Cargando…
Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome
BACKGROUND: Phelan-McDermid syndrome (PMS) is caused by haploinsufficiency of the SHANK3 gene and is characterized by global developmental delays and autism spectrum disorder (ASD). Based on several converging lines of preclinical and clinical evidence supporting the use of insulin-like growth facto...
Autores principales: | Kolevzon, A., Breen, M. S., Siper, P. M., Halpern, D., Frank, Y., Rieger, H., Weismann, J., Trelles, M. P., Lerman, B., Rapaport, R., Buxbaum, J. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994375/ https://www.ncbi.nlm.nih.gov/pubmed/35395866 http://dx.doi.org/10.1186/s13229-022-00493-7 |
Ejemplares similares
-
A proof-of-concept study of growth hormone in children with Phelan–McDermid syndrome
por: Sethuram, S., et al.
Publicado: (2022) -
A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
por: Fastman, J., et al.
Publicado: (2021) -
Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome
por: Wang, A. Ting, et al.
Publicado: (2016) -
Neural Markers of Auditory Response and Habituation in Phelan-McDermid Syndrome
por: Isenstein, Emily L., et al.
Publicado: (2022) -
Erratum to: Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome
por: Wang, A. Ting, et al.
Publicado: (2016)